Dr. Condon is the Associate Director of the National Institute on Drug Abuse (NIDA). He also serves as the Director of NIDA's Office of Science Policy and Communications. In these roles, Dr. Condon oversees the Institute's science planning, policy, congressional, and communications activities and coordinates NIDA's research training and science education programs. Prior to coming to NIDA, Dr. Condon served in several senior science policy positions at the former Alcohol, Drug Abuse, and Mental Health Administration and the U.S. Congress, Office of Technology Assessment. Dr. Condon received his Ph.D. in the neurosciences at the Department of Physiology, College of Medicine, Ohio State University, and conducted postdoctoral work in neuroendocrinology and neurophysiology at the University of California at Los Angeles and the Oregon Health Sciences University.

Dr. Turkkan is Chief of the Behavioral Sciences Research Branch (Division of Basic Research) at the National Institute on Drug Abuse (NIDA). She was trained in experimental psychology at the City University of New York and continued her research career at the Johns Hopkins University (JHU) School of Medicine, where she directed a behavioral physiology laboratory. Most recently, she was an Associate Professor of Behavioral Biology in the Department of Psychiatry and Behavioral Sciences at JHU. She came to NIDA in 1994 to broaden the Institute's support of research in basic behavioral and cognitive sciences. The Behavioral Sciences Research Branch supports research on a wide array of licit and illicit drugs and has a strong portfolio in smoking-related and nicotine-specific research in areas such as craving, emotion, and decision processes that lead to first drug use or relapse to drug abuse. Also supported in the Branch is research on smoking sensory factors, patterns of smoking, cognitive expectancies, genetic influences, and individual differences, in both animal and human research models.